Professional Documents
Culture Documents
PERIFER
BY
WINANGUN
PENDAHULUAN
PENYAKIT ARTERI &VENA PERIFER
PENYAKIT NON KARDIAK, LIBATKAN
SELURUH SIRKULASI.
SYNDROMA FATOFISIOLOGY ARTERI, VENA
DAN SYSTEM LIMPATIK.
KELAINAN VASKULER UMUM,
PERIPHERAL ARTERIAL DESEASE ( PAOD )
MASALAH KESEHATAN GERIATRI
PREVALELENSI 4,3% USIA 40TH ,14,5 % USIA >>
70TH RATA2 1,6- 12 %
Veins
are thin-walled vessels that transport
deoxygenated blood
from the capillaries back to the right side
of the heart
Varicose Veins
SOURCES OF BRAIN ISCHEMIC / INFARCTION
PATHOGENESIS
PROSES PENYAKIT SYSTEMIK
PENGARUH SIRKULASI MULTIPLE,
PROSES PATOGENSEIS SYSTEMIK >>
ATHEROSKLEROSIS
KELAINAN DEGENERATIF KRONIK,
DYSPLASIA
INFLAMASI VASKULER/ ARTERITIS
TROMBUS IN SITU TROMBOEMBOLI
VASKULITIS ARTERI BESAR, SEDANG ,
KECIL
INCIDEN >> USIA LEBIH 40TH
KEJADIAN TERTINGGI DEKADE 6-7
PAP MENGENAI ARTERI BESAR
SEDANG,KECIL
TROMBOANGITIS OBLITERANS,
FIBROMUSCULER DYSPLASIA,
PREVALENSI ↑↑ PADA MANULA, HT, DM
DYSLEPEDEMIA,
HYPERHOMOSYSTEINEMIA
PEROKOK DAN GGK.
PX
ATHEROSKLEROSIS TUMPUKAN LAPISAN
LEMAK & KOLESTEROL ATEROMA
FIBROFROLIFERATIF & SEL BUSA
PERUBAHAN UKURAN INTIMA DAN LUMEN
ARTERI
STENOSIS DAN OKLUSI AKUT ARTERI
SYNDROMA ISKEMIK KRONIK GANGGREN
LAMA DAN PARAHNYA DM ≈≈> PAP ↑↑.
OKUSI ARTERI TIBIALIS MIKRO ANGIOPATI
GG PENYEMBUHAN LUKA GANGGREN
Pathophysiology
the great and small
saphenous veins are most
often involved
weakening of the vein wall
does not withstand normal
pressure
valves become stretched
and incompetent
Adhesi tombosit
Endothelial Dysfunction
From first decade From third decade From fourth decade
Smooth muscle Thrombosis,
Growth mainly by lipid accumulation and collagen hematoma
Platelet
Plaque Thrombus
adhesion,
rupture formation
activation, and
aggregation
Lumen
Endothelium
Thrombus
Platelets
Thick Thin
Fibrous Cap Fibrous Cap
Collagen
Gpla/lla bind
Lipid
core
5 HT
TXA2
TINDAKAN LAIN:
REHABILITASI MEDIS PENDERITA.
Obat - Obat Antiplatelet
Thromboxane A2 inhibitor
– Acetylsalicylic acid (ASA)
Phosphodiesterase inhibitor
– Dipyridamole
Glycoprotein (GP) IIb/IIIa blockers
– Parenteral: abciximab, eptifibatide, tirofiban
ADP-receptor antagonists
– Clopidogrel ( Plavix )
– Ticlopidine ( Ticlid , Agulan , Ticuring )
Medical Management
Superficial thrombophlebitis
bed rest with legs elevated
apply moist heat
NSAID’s ( Non – steroidal anti-inflammatory drugs) - aspirin
Deep vein thrombosis
requires hospitalization
bed rest w/ legs elevated to 15-20 degrees above heart level
( knees slightly flexed, trunk horizontal (head may be raised) to
promote venous return and help prevent further emboli and
prevent edema
application of warm moist heat to reduce pain, promotes
venous return
elastic stocking or bandage
anticoagulants, initially with IV heparin then coumadin
fibrinolytic to resolve the thrombus
vasodilator if needed to control vessel spasm and improve
circulation
Surgical Intervention
indicated or done for prevention or relief of
edema, for recurrent leg ulcers or pain or for
cosmetic purposes
Vein ligation and stripping
the great sapheneous vein is ligated (tied)
close to the femoral junction
the veins are stripped out through small
incisions at the groin, above & below the
knee and at the ankles.
sterile dressing are placed over the incisions
and an elastic bandage extending from the
foot to the groin is firmly applied
Vein ligation and stripping
Recommended Initial Antiplatelet Therapy for Patients With
Transient Ischemic Attack or Ischemic Stroke and Subsequent Therapy
for Recurrent Ischemic Events & pad
Aspirin Plus
Aspirin Clopidogrel† Aspirin Clopidogrel† Extended-Release
Dipyridamole‡
Recurrent Recurrent
Recurrent Recurrent Recurrent
TIA/Stroke TIA/Stroke ACS ACS ACS
TIA/Stroke TIA/Stroke TIA/Stroke
or ACS or ACS
Clopidogrel Clopidogrel
Aspirin and Aspirin and Aspirin and Aspirin and Aspirin and Clopidogrel
or or
Clopidogrel Clopidogrel Clopidogrel Clopidogrel Clopidogrel or
Aspirin and Aspirin and or Aspirin and
Clopidogrel Clopidogrel Aspirin and Clopidogrel
or Axtended-
Aspirin and Release
Axtended- Dipyridamole‡
Release
Dipyridamole‡
Abbreviations: ACS indicates acute coronary syndrome; TIA, transient ischemic attack.
*Per the Antithrombotic Trialists’ Collaboration.2
†Per the CAPRIE Steering Committee.21
‡Per Diener et al24 and De Schryver et al.28
JAMA, October 20, 2004—Vol 292, No. 15
TROMBOANGIITIS OBLITERAN/(BUERGER
DESEASE)
O'Donnell, TF Jr. The present status of surgery of the superficial venous system in the
management of venous ulcer and the evidence for the role of perforator interruption. J Vasc
Surg 2008; 48:1044.
Galland, RB, Magee, TR, Lewis, MH. A survey of current attitudes of British and Irish vascular
surgeons to venous sclerotherapy. Eur J Vasc Endovasc Surg 1998; 16:43.
Microsclerotherapy
30 g butterfly needle
0.2% STS
Several courses required
benefit compression
Endovenous Laser
Surface laser therapy
Telangiectasias,
reticular veins and
small varicose veins
<5mm
Not used for larger
varicose veins
Subfascial endoscopic perforator
vein ligation (SEPS)
Contraindications
Systemic illness
Tortuous vein
Hypercoagulable state
Pregnancy
Obstructed Deep veins